["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
Luft
D
D
Abt. Innere Medizin IV, Med. Universitäts- und Poliklinik, Eberhard-Karls-Universität, Tübingen. drluft@med.uni-tuebingen.de
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004359:Drug Therapy, Combination; D006321:Heart / Q000294:innervation; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D048289:Imidazolidines; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007093:Imidazoles; D048289:Imidazolidines; D000449:Aldehyde Reductase; C026411:sorbinil